Centene Corporation (NYSE:CNC) has reportedly had a
strong Q1 2025 financial performance, surpassing forecasts with increased revenue and beating earnings per share (EPS) estimates. Even so, the health insurer's stock faced a decline due to concerns about Medicaid, despite reassurances from CNBC's Jim Cramer, who called the stock a 'gem'. The company's
outlook for 2025 remains robust, with raised revenue guidance based on higher health plan sales. Also, CNC's management has undertaken strategic moves, reaffirmed annual profit guidance, and anticipated strong full year sales, even amid policy challenges. Moreover, CNC has been recognized among the
best health insurance stocks to buy in 2025. On the downside, despite an earnings growth over the last three years, this has not translated into gains for the CNC's shareholders, leading to a 34% loss over that period.
Centene Corporation CNC News Analytics from Tue, 22 Oct 2024 07:00:00 GMT to Sat, 26 Apr 2025 12:28:21 GMT -
Rating 6
- Innovation 3
- Information 8
- Rumor -4
